Synthesis, Docking and Anticancer Evaluation of New Pyridine-3-Carbonitrile Derivatives

References

• S. I. Elewa, A. O. Abdelhamid, A. A. Hamed, and E. A. Mansour, “Synthesis, Characterization , Antimicrobial Activities, Anticancer of Some New Pyridines from 2, 3-Dihydro-2-Oxo-4-Phenyl-6-(Thien-2-yl)Pyridine-3-Carbonitrile,” Synthetic Communications (2021) (In Press).
   Web of Science ®Google Scholar
• M. H. Forouzanfar, K. J. Foreman, A. M. Delossantos, R. D. Lozano, A. D. Lopez, C. J. Murray, and M. Naghavi, “Breast and Cervical Cancer in 187 Countries between 1980 and 2010: A Systematic Analysis”. The Lancet 378, no. 9801 (2011): 1461–84.
   PubMed Web of Science ®Google Scholar
• O. J. Shaughnessy, “Extending Survival with Chemotherapy in Metastatic Breast Cancer,” The Oncologist 10, no. Supplement 3 (2005): 20–9.
   PubMedGoogle Scholar
• R. M. Abdelhameed, H. A. El-Sayed, M. El-Shahat, A. A. El-Sayed, and O. M. Darwesh, " “Novel Triazolothiadiazole and Triazolothiadiazine Derivatives Containing Pyridine Moiety: Design, Synthesis, Bactericidal and Fungicidal Activities,” Current Bioactive Compounds 14, no. 2 (2018): 169–79.
   Google Scholar
• N. Wind, and I. Holen, “Multidrug Resistance in Breast Cancer: From in Vitro Models to Clinical Studies,” International Journal of Breast Cancer 2011, (2011): 967419– 2.
   PubMedGoogle Scholar
• A. Perez-Rebolledo, J. D. Ayala, G. M. de Lima, N. Marchini, G. Bombieri, C. L. Zani, E. M. Souza-Fagundes, and H. Beraldo, “Structural Studies and Cytotoxic Activity of N(4)-phenyl-2-Benzoylpyridine Thiosemicarbazone Sn(IV) Complexes,” European Journal of Medicinal Chemistry 40, no. 5 (2005): 467–72.
   PubMed Web of Science ®Google Scholar
• A. Kamal, M. N. A. Khan, K. S. Reddy, and K. Rohini, “Synthesis of a New Class of 2-Anilino Substituted Nicotinyl Arylsulfonylhydrazides as Potential Anticancer and Antibacterial Agents,” Bioorganic & Medicinal Chemistry 15, no. 2 (2007): 1004–13. no.
   PubMed Web of Science ®Google Scholar
• V. Onnis, M. T. Cocco, V. Lilliu, and C. Congiu, “Synthesis and Evaluation of Antitumoral Activity of Ester and Amide Derivatives of 2-Arylamino-6-Trifluoromethyl-3-Pyridinecarboxylic Acids,” Bioorganic & Medicinal Chemistry 16, no. 5 (2008): 2367–78.
   PubMed Web of Science ®Google Scholar
• A. H. Abadi, T. M. Ibrahim, K. M. Abouzid, J. Lehmann, H. N. Tinsley, B. D. Gary, and G. A. Piazza, “Design, Synthesis and Biological Evaluation of Novel Pyridine Derivatives as Anticancer Agents and Phosphodiesterase 3 Inhibitors,” Bioorganic & Medicinal Chemistry 17, no. 16 (2009): 5974–82.
   PubMed Web of Science ®Google Scholar
• H. A. El-Sayed, A. H. Moustafa, A. E.-F Z. Haikal, R. Abu-El-Halawa, and HEl. Sayed, “Synthesis, Antitumor and Antimicrobial Activities of 4-(4-Chlorophenyl)-3-Cyano-2-(β-O-Glycosyloxy)-6-(Thien-2-yl)-Nicotinonitrile,” European Journal of Medicinal Chemistry 46, no. 7 (2011): 2948–54.
   PubMed Web of Science ®Google Scholar
• V. Onnis, M. T. Cocco, R. Fadda, and C. Congiu, “Synthesis and Evaluation of Anticancer Activity of 2-Arylamino-6-Trifluoromethyl-3-(Hydrazonocarbonyl)Pyridines,” Bioorganic & Medicinal Chemistry 17, no. 17 (2009): 6158–65.
   PubMed Web of Science ®Google Scholar
• A. Carbone, M. Pennati, P. Barraja, A. Montalbano, B. Parrino, V. Spanò, A. Lopergolo, S. Sbarra, V. Doldi, N. Zaffaroni, et al. “ Synthesis and Antiproliferative Activity of Substituted 3[2-(1H-indol-3-yl)- 1,3-thiazol-4-yl]-1H-pyrrolo[3,2-b]Pyridines, Marine Alkaloid Nortopsentin Analogues,” Current Medicinal Chemistry 21, no. 14 (2014): 1654–66.
   PubMed Web of Science ®Google Scholar
• Anna Carbone, Marzia Pennati, Barbara Parrino, Alessia Lopergolo, Paola Barraja, Alessandra Montalbano, Virginia Spanò, Stefania Sbarra, Valentina Doldi, Michelandrea De Cesare, et al. “Novel 1H-pyrrolo[2,3-b]pyridine derivative nortopsentin analogues: synthesis and antitumor activity in peritoneal mesothelioma experimental models ,” Journal of Medicinal Chemistry 56, no. 17 (2013): 7060–72.
   PubMed Web of Science ®Google Scholar
• Anna Carbone, Barbara Parrino, Gloria Di Vita, Alessandro Attanzio, Virginia Spanò, Alessandra Montalbano, Paola Barraja, Luisa Tesoriere, Maria Antonia Livrea, Patrizia Diana, et al. “Synthesis and Antiproliferative Activity of Thiazolyl-Bis-Pyrrolo[2,3-b]Pyridines and Indolyl-Thiazolyl-Pyrrolo[2,3-c]Pyridines, Nortopsentin Analogues,” Marine Drugs 13, no. 1 (2015): 460–92.
   PubMed Web of Science ®Google Scholar
• E. M. Flefel, W. A. Tantawy, W. I. El-Sofany, M. El-Shahat, A. A. El-Sayed, and D. N. Abd-Elshafy, “Synthesis of Some New Pyridazine Derivatives for anti-HAV Evaluation,” Molecules 22, no. 1 (2017): 148.
   Web of Science ®Google Scholar
• P. Thapa, R. Karki, U. Thapa, Y. Jahng, M.-J. Jung, J. M. Nam, Y. Na, Y. Kwo, and E.-S. Lee, “ 2-Thienyl-4-furyl-6-aryl Pyridine Derivatives: Synthesis, Topoisomerase I and II inhibitory Activity, Cytotoxicity, and Structure-Activity Relationship Study,” Bioorganic & Medicinal Chemistry 18, no. 1 (2010): 377–86.
   PubMed Web of Science ®Google Scholar
• K.-Y. Jun, H. Kwon, S.-E. Park, E. Lee, R. Karki, P. Thapa, J.-H. Lee, E.-S. Lee, and Y. Kwon, “Discovery of Dihydroxylated 2,4-Diphenyl-6-Thiophen-2-yl-Pyridine as a Non-Intercalative DNA-Binding Topoisomerase II-Specific Catalytic Inhibitor,” European Journal of Medicinal Chemistry 80, (2014): 428–38.
   PubMed Web of Science ®Google Scholar
• R. Karki, C. Song, T. M. Kadayat, ; T. B. T. Magar, Bist, A. Shrestha, Y. Na, Y. Kwon, and E.-S. Lee, “Topoisomerase I and II Inhibitor G.y Activity, Cytotoxicity, and Structure–Activity Relationship Study of Dihydroxylated 2, 6-Diphenyl-4-Aryl Pyridines,”Bioorganic & Medicinal Chemistry 23, no. 13 (2015): 3638–54.
   PubMed Web of Science ®Google Scholar
• A. J. Kraker, B. G. Hartl, A. M. Amar, M. R. Barvian, H. H. Showalter, and C. W. Moore, “Biochemical and Cellular Effects of c-Src Kinase-Selective Pyrido [2, 3-d] Pyrimidine Tyrosine Kinase Inhibitors,” Biochemical Pharmacology 60, no. 7 (2000): 885–98.
   PubMed Web of Science ®Google Scholar
• M. M. Moasser, M. Srethapakdi, K. S. Sachar, A. J. Kraker, and N. Rosen, “Inhibition of Src Kinases by a Selective Tyrosine Kinase Inhibitor Causes Mitotic Arrest,” Cancer Research 59, no. 24 (1999): 6145–52.
   PubMed Web of Science ®Google Scholar
• K. Chand, S. Prasad, R. K. Tiwari, A. N. Shirazi, S. Kumar, K. Parang, and S. K. Sharma, “Synthesis and Evaluation of c-Src Kinase Inhibitory Activity of pyridin-2(1H)-one derivatives ,” Bioorganic Chemistry 53, (2014): 75–82.
   PubMed Web of Science ®Google Scholar
• A. Tiwari, W. R. Waud, and R. F. Struck, “Determination of the Phamacophore of Penclomedine, a Clinically-Evaluated Antitumor Pyridine Derivative,” Bioorganic & Medicinal Chemistry 10, no. 11 (2002): 3593–8.
   PubMed Web of Science ®Google Scholar
• A. A. El-Sayed, N. Y. Khaireldin, M. El-Shahat, E. A. El-Hefny, M. M T. El-Saidi, M. M. Ali, and Abeer E. Mahmoud, “Anti Proliferative Activity for Newly Heterofunctionalized Pyridine Analogues,” Ponte 72, (2016): 106–18.
   Google Scholar
• M. T. Cocco, C. Congiu, V. Lilliu, and, V. Onnis, “Synthesis and Antiproliferative Activity of 2,6-Dibenzylamino-3,5-Dicyanopyridines on Human Cancer Cell Lines ,” European Journal of Medicinal Chemistry 40 no. 12 (2005): 1365–72.
   PubMed Web of Science ®Google Scholar
• A. E. Rashad, A. H. Shamroukh, M. A. El-Hashash, A. F. El-Farargy, N. M. Yousif, M. A. Salama, N. M. Abdelwahed, and M. 1El-Shahat, “3-Bis (4-Chlorophenyl)-2, 3-Epoxypropanone as Synthons in Synthesis of Some Interesting Potential Antimicrobial Agents,” Organic Chemistry: An Indian Journal 9, (2013): 287–94.
   Google Scholar
• S. A. Rostom, H. M. Faidallah, and M. S. Al-Saadi, “A Facile Synthesis of Some 3-Cyano-1, 4, 6-Trisubstituted-2 (1H)-Pyridinones and Their Biological Evaluation as Anticancer Agents,” Medicinal Chemistry Research 20, no. 8 (2011): 1260–72.
   Web of Science ®Google Scholar
• I. F. Nassar, S. R. Atta-Allah, and A.-S H. Elgazwy, “A Convenient Synthesis and Molecular Modeling Study of Novel pyrazolo[3,4-d]Pyrimidine and Pyrazole Derivatives as Anti-Tumor Agents,” Journal of Enzyme Inhibition and Medicinal Chemistry 30, no. 3 (2015): 396–405.
   PubMed Web of Science ®Google Scholar
• I. F. Nassar, A. F. El Farargy, F. M. Abdelrazek, and N. S. Ismail, “Design, Synthesis and Anticancer Evaluation of Novel Pyrazole, Pyrazolo [3, 4-d] Pyrimidine and Their Glycoside Derivatives,” Nucleosides, Nucleotides and Nucleic Acids 36, no. 4 (2017): 275–91.
   PubMed Web of Science ®Google Scholar
• N. H. Metwally, F. M. Abdelrazek, and S. M. Eldaly, “Synthesis, Molecular Docking, and Biological Evaluation of Some Novel Bis‐Heterocyclic Compounds Based N, N′‐([1, 1′‐Biphenyl]‐4, 4′‐Diyl) Bis (2‐Cyanoacetamide) as Potential Anticancer Agents,” Journal of Heterocyclic Chemistry 55, no. 12 (2018): 2668–82.
   Web of Science ®Google Scholar
• A. F. Kassem, I. F. Nassar, M. T. Abdel-Aal, H. M. Awad, and W. A. El-Sayed, “Synthesis and Anticancer Activity of New ((Furan-2-yl)-1,3,4-Thiadiazolyl)-1,3,4-Oxadiazole Acyclic Sugar Derivatives ,” Chemical & Pharmaceutical Bulletin 67, no. 8 (2019): 888–95.
   PubMed Web of Science ®Google Scholar
• I. F. Nassar, D. S. El Kady, H. M. Awad, and W. A. El‐Sayed, “Design, Synthesis, and Anticancer Activity of New Oxadiazolyl‐Linked and Thiazolyl‐Linked Benzimidazole Arylidines, Thioglycoside, and Acyclic Analogs,” Journal of Heterocyclic Chemistry 56, no. 3 (2019): 1086–100. no.
   Web of Science ®Google Scholar
• I. F. Nassar, W. A. El-Sayed, T. I. Ragab, A. S. G. Shalaby, and A. Mehany, “Design, Synthesis of New Pyridine and Pyrimidine Sugar Compounds as Antagonists Targeting the ERα via Structure-Based Virtual Screening,” Mini Reviews in Medicinal Chemistry 19, no. 5 (2019): 395–409. no.
   PubMed Web of Science ®Google Scholar
• A. A. Abdel Rahman, I. F. Nassar, A. K. Shaban, D. S. EL-Kady, H. M. Awad, and W. A. El Sayed, “Synthesis, Docking Studies into CDK-2 and Anticancer Activity of New Derivatives Based Pyrimidine Scaffold and Their Derived Glycosides,” Mini Reviews in Medicinal Chemistry 19, no. 13 (2019): 1093–110.
   PubMed Web of Science ®Google Scholar
• E. M. Flefel, W. I. El-Sofany, H. M. Awad, and Mahmoud. El-Shahat, “First Synthesis for Bis-Spirothiazolidine Derivatives as a Novel Heterocyclic Framework and Their Biological Activity,” Mini Reviews in Medicinal Chemistry 20, no. 2 (2020): 152–60.
   PubMed Web of Science ®Google Scholar
• D. M. Masoud, R. A. Azzam, S. H. Hussein, A. A. I. Mekawey, and H. A. Abdel-Aziz, “Synthesis of Some Novel Substituted Nicotines and Evaluation of Their Antimicrobial Activity,” Egyptian Journal of Chemistry 63, no. 9 (2020): 791–803.
   Google Scholar
• A. A. Hovhannisyan, L. H. Aristakesyan, R. M. Hakobyan, and G. S. Melikyan, “Synthesis of New 3-Cyanopyridine-2(1H)-Ones with Unsaturated Substituents at C-4,” Chemistry and Biology 2, (2015) : 9–13.
   Google Scholar
• A. Piroyan, and G. Melikyan, “Convenient Synthetic Route to 3-cyanopyridine2(1H)-One Derivatives with Aromatic Substituents,” Heterocyclic Communications 18, no. 5-6 (2012): 233–7.
   Web of Science ®Google Scholar
• R. M. Fekry, H. A. El-Sayed, M. G. Assy, A. Shalby, and A. S. Mohamed, “Synthesis and Anticancer Activity of Some Novel Fused Nicotinonitrile Derivatives,” Organic Chemistry: Current Research 05, no. 03 (2016): 1–4.
   Google Scholar
• N. N. Farshori, Abdul. Rauf, M. A. Siddiqui, E. S. Al-Sheddi, and M. M. Al-Oqail, “A Facile One-Pot Synthesis of Novel 2, 5-Disubstituted-1,3,4-Oxadiazoles under Conventional and Microwave Conditions and Evaluation of Their in Vitro Antimicrobial Activities,” Arabian Journal of Chemistry 10, (2017): S2853–S2861.
   Web of Science ®Google Scholar
• E. E. El-Arab, “Synthesis and Cytotoxicity of Novel Pyrazole Derivatives Derived from 3-Methyl-1-Phenyl-1Hpyrazol-5(4H)-One,” Egyptian Journal of Chemistry. 58, no. 6 (2015): 741–53.
   Web of Science ®Google Scholar
• S. K. Karrouchi, S. Radi,. Ramli, J. Taoufik, YN. Mabkhot, F. A. Al-Aizari, and A. M. Ansar, “Synthesis and Pharmacological Activities of Pyrazole Derivatives,” Molecules 23, no. 1 (2018): 134. 1–85
   PubMed Web of Science ®Google Scholar
• T. Elsaman, M. Fares, H. A. Abdel-Aziz, M. I. Attia, H. A. Ghabbour, and K. M. Dawood, " “A Facile Synthesis of Pyrido[2',3':3,4]Pyrazolo[1,5-a]Pyrimidine and Pyrido [2',3':3,4] Pyrazolo[5,1-c][1,2,4]Triazine Bearing a Thiophene Moiety,” Journal of Chemistry 2013, (2013) : 1–7.
   Web of Science ®Google Scholar
• N. Kornblum, P. J. Berrigan, and W. J. Le Noble, “Solvation as a Factor in Alkylation of Ambident Anions: The Importance of Hydrogen Bonding Capacity of the Solvent,” Journal of the American Chemical Society 85, no. 8 (1963): 1141–7.
   Web of Science ®Google Scholar
• N. Galic, B. Peric, B. Joji-Prodic, and Z. Cimeriman, " “Structural and Spectroscopic Characteristics of Aroylhydrazones Derived from Nicotinic Acid Hydrazide,” Journal of Molecular Structure. 559, (2001): 187–94.
   Web of Science ®Google Scholar
• F. N. Ibrahim, F. E. Ahmed, M. A. Fathy, and H. Zeinab, “Synthesis of New Uracil Derivatives and Their Sugar Hydrazones with Potent Antimicrobial, Antioxidant and Anticancer Activities,” Ncleosides, Nucleotides & Nucleic Acids 39, (2020): 991–1010.
   PubMed Web of Science ®Google Scholar
• F. N. Ibrahim, F. E. Ahmed, and M. A. Fathy, “Synthesis and Anticancer Activity of Some New Fused Pyrazoles and Their Glycoside Derivatives,” Journal of HeterocyclicChemistry 55, (2018): 1709–19.
   Web of Science ®Google Scholar
• Y. A. Ibrahim, B. Haider, R. I. Maher, and N. M. Rana, “Efficient Synthesis of 16-28 Membered Macrocyclic Crown Amides via Ring Closing Metathesis,” Tetrahedron 59, no. 37 (2003): 7273–82.
   Web of Science ®Google Scholar
• A. M A. Khaled, H. A. Ghada, and M. E. Abeer, “Eco-Friendly Synthesis of Novel Cyanopyridine Derivatives and Their Anticancer and PIM-1 Kinase Inhibitory Activities,” European Journal of Medicinal Chemistry 134, (2017): 357–65.
   PubMed Web of Science ®Google Scholar
• Elżbieta Wyrzykiewicz, and Dorota Prukała, “New Isomeric N-Substituted Hydrazones of 2-, 3- and 4-Pyridinecarboxaldehydes,”Journal of Heterocyclic Chemistry 35, no. 2 (1998): 381–7.
   Web of Science ®Google Scholar
• S. Mohan, and S. Ananthan, “A New Approach for the Synthesis of Some Novel Sulphur Bridged Pyrazoles and Their Characterization,” Journal of Chemical and Pharmaceutical Research3, (2011): 402–13.
   Google Scholar
• E. E. Ibrahim, A. M. Abdel-Mohsen, A. A. Amer, M. G F. Moustafa, S. A. Salem, A. E. Maher, and J. Jancar, “Synthesis, Biological, anti-Inflammatory Activities and Quantum Chemical Calculation of Some [4-(2, 4, 6-Trimethylphenyl)-1(2H)-Oxo-Phthalazin-2yl] Acetic Acid Hydrazide Derivatives,” Dyes and Pigments 113, (2015): 357–71.
   Web of Science ®Google Scholar
• M. A. Elsayed, S. S. Elmorsy, S. M. Abdelmageed, and E. Z. Zaki, “Synthesis of Some New Hydrazide-Hydrazones Related to Isatin and Its Mannich and Schiffbases,” Zeitschrift Für Naturforschung B 71, no. 11 (2016): 1147–57.
   Google Scholar
• B. Samir, K. Wesam, and A. F. Ahmed, “Utility of 1‐Chloro‐3,4‐Dihydronaphthalene‐2‐Carboxaldehyde in the Synthesis of Novel Heterocycles with Pharmaceutical Interest,” Synthetic Communications 36, (2006): 1601–12.
   Web of Science ®Google Scholar
• A. A. Ameen, A. R. Hoda, and K. M. A. Hussein, “Synthesis of Novel 1, 2, 4-Triazolopyrimidines and Their Evaluation as Antimicrobial Agents,” Medicinal Chemistry Research 26, no. 1 (2017): 120–30.
   Web of Science ®Google Scholar
• K. Takahashi, M. Tanaka, A. Inagaki, H. Wanibuchi, Y. Izumi, K. Miura, K. Nagayama, M. Shiota, and H. Iwao, “Establishment of a 5-Fluorouracil-Resistant Triple-Negative Breast Cancer Cell Line,” International Journal of Oncology 43no. 6 (2013): 1985–91.
   PubMed Web of Science ®Google Scholar
• A. A. Ahmed, B. S. Aziza, and H. A. Hanaa, “Selenium Nanoparticles Induce the Chemo-Sensitivity of Fluorouracil Nanoparticles in Breast and Colon Cancer Cells,” Biological Trace Element Research 187, no. 1 (2019): 80–91.
   PubMed Web of Science ®Google Scholar
• F. K. Asmaa, M. H. A. Eman, S. E. Dina, M. A. Hanem, and A. E. Wael, “Design, Synthesis and Anticancer Activity of New Thiazole-Tetrazole or Triazole Hybrid Glycosides Targeting CDK-2 via Structure-Based Virtual Screening,” Mini-Reviews in Medicinal Chemistry 19, (2019): 933–48.
   PubMed Web of Science ®Google Scholar
• E. M. Flefel, W. I. El-Sofany, R. A. Al-Harbi, and M. El-Shahat, “Development of a Novel Series of Anticancer and Antidiabetic: Spirothiazolidines Analogs,” Molecules 24, no. 13 (2019): 2511.
   Web of Science ®Google Scholar
• A. A. Abd-Rabou, and H. H. Ahmed, “CS-PEG Decorated PLGA Nano-Prototype for Delivery of Bioactive Compounds: A Novel Approach for Induction of Apoptosis in HepG2 Cell Line,” Advances in Medical Sciences 62, no. 2 (2017): 357–67.
   PubMed Web of Science ®Google Scholar
• E. M. Flefel, W. I. El-Sofany, M. El-Shahat, A. Naqvi, and E. Assirey, “Synthesis, Molecular Docking and in Vitro Screening of Some Newly Synthesized Triazolopyridine, Pyridotriazine and Pyridine–Pyrazole Hybrid Derivatives,” Molecules 23, no. 10 (2018): 2548.
   Web of Science ®Google Scholar
• G. Kaminski, and W. L. Jorgensen, “Performance of the AMBER94, MMFF94, and OPLS-AA Force Fields for Modeling Organic Liquids,” The Journal of Physical Chemistry 100, no. 46 (1996): 18010–3. no.
   Web of Science ®Google Scholar
• M. F. Lensink, R. Méndez, and S. J. Wodak, “Docking and Scoring Protein Complexes: CAPRI 3rd Edition,” Proteins: Structure, Function, and Bioinformatics 69, no. 4 (2007): 704–18.
   PubMed Web of Science ®Google Scholar